ArticleEuropean heart journal2020

Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care.

Milton PackerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.